The IGF1R and IR expression and localisation were investigated by IHC in a cohort of patients with ACC (n = 118), including both primary tumours (n = 107) and local recurrences or distant metastases (n = 11), and ACA (n = 22) and association with clinicopathological features was assessed. Here, IGF1R is linked to adrenal cortex carcinoma.